In this context, the trace N-glycan biomarkers identified in our study, especially SGm1 and SGm2, could have important clinical implications for the diagnosis of RA as they are RF/ACPA-independent and RA-specific. The gene discussed is PRTN3; the disease is rheumatoid arthritis.